Abstract
Enchondroma is a common benign intramedullary neoplasm, composed of mature hyaline cartilage. Enchondromas account for 10–25 % of all benign bone tumors. It is more frequent in females. Most common from the second to the sixth decades with a peak in the fourth and fifth decades.
It is most frequently found on the small tubular bones of the hands. Among the long tubular bones, enchondroma occurs more frequently in the proximal humerus and proximal and distal femur and tibia. Histological features are variable according to the location of the lesion. Accordingly, it is very important to consider the location of the lesion together with the radiological findings and clinical features. Enchondromas are composed of mature hyaline cartilage arranged in lobules. Cartilaginous lobules are surrounded by normal bone marrow. When treatment is needed, simple curettage is the appropriate treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
Alho A, Skjeldal S, Pettersen EO, et al. Aneuploidy in benign tumors and nonneoplastic lesions of musculoskeletal tissues. Cancer. 1994;73:1200–5.
Bovee J, van Roggen JFG, Cleton-Jansen AM, et al. Malignant progression in multiple enchondromatosis (Ollier’s disease): an autopsy-based molecular genetic study. Hum Pathol. 2000;31:1299–303.
Bridge JA, Persons DL, Neff JR, Bhatia P. Clonal karyotypic aberrations in enchondromas. Cancer Detect Prev. 1992;16:215–9.
Buddingh EP, Naumann S, Nelson M, et al. Cytogenetic findings in benign cartilaginous neoplasms. Cancer Genet Cytogenet. 2003;141:164–8.
Culver Jr JE, Sweet DE, McCue FC. Chondrosarcoma of the hand arising from a pre-existent benign solitary enchondroma. Clin Orthop Relat Res. 1975;113:128–31.
Dahlen A, Mertens F, Rydholm A, et al. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol. 2003;16:1132–40.
Gunawan B, Weber M, Bergmann F, et al. Clonal chromosome abnormalities in enchondromas and chondrosarcomas. Cancer Genet Cytogenet. 2000;120:127–30.
Hopyan S, Gokgoz N, Poon R, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet. 2002;30:306–10.
Kusuzaki K, Murata H, Takeshita H, et al. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas. Mod Pathol. 1999;12:863–72.
Landman AS, Danielian PS, Lees JA. Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation. Oncogene. 2013;32:4798–805.
Mirra JM. Intramedullary cartilage- and chondroid-producing tumors. In: Bone tumors. Clinical, radiologic, and pathologic correlations. Philadelphia: Lee & Febiger; 1989.
Morrison C, Radmacher M, Mohammed N, et al. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. J Clin Oncol. 2005;23:9369–76.
Ozaki T, Wai D, Schafer KL, et al. Comparative genomic hybridization in cartilaginous tumors. Anticancer Res. 2004;24:1721–5.
Ozisik YY, Meloni AM, Spanier SS, et al. Deletion 1p in a low-grade chondrosarcoma in a patient with Ollier disease. Cancer Genet Cytogenet. 1998;105:128–33.
Pansuriya TC, van Eijk R, d’Adamo P, et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011;43:1256.
Rozeman LB, Sangiorgi L, Briaire-de Bruijn IH, et al. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutations p.R150 C. Hum Mutat. 2004;24:466–73.
Rozeman LB, Hameetman L, Cleton-Jansen AM, et al. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas. J Pathol. 2005;205:476–82.
Sawyer JR, Swanson CM, Luckacs JL, et al. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors. Cancer. 1998;82:474–83.
Schajowicz F. Cartilage forming tumors. In: Tumors and tumor like lesions of bone. 2nd ed. Berlin: Springer; 1994. p. 141–59.
Shimizu K, Kotoura Y, Nishijima N, Nakamura T. Enchondroma of the distal phalanx of the hand. J Bone Joint Surg Am. 1997;79:898–900.
Teyssier JR, Ferre D. Frequent clonal chromosomal changes in human non-malignant tumors. Int J Cancer. 1989;44:828–32.
Unni KK. Dahlin’s bone tumors, General aspects and data on 11087 cases. 5th ed. Philadelphia: Lippincott-Raven; 1996. p. 25–40.
Van Beerendonk HM, Rozeman LB, Taminiau AHM, et al. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumor progression. J Pathol. 2004;202:359–66.
Yu C, Le AT, Yeger H, et al. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia. J Pathol. 2003;201:609–15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Park, YK. (2015). Enchondroma. In: Santini-Araujo, E., Kalil, R., Bertoni, F., Park, YK. (eds) Tumors and Tumor-Like Lesions of Bone. Springer, London. https://doi.org/10.1007/978-1-4471-6578-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6578-1_16
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6577-4
Online ISBN: 978-1-4471-6578-1
eBook Packages: MedicineMedicine (R0)